Cargando…
The optimization of cell therapy by combinational application with apicidin-treated mesenchymal stem cells after myocardial infarction
Although mesenchymal stem cells (MSC) have been shown to be safe in preclinical studies of cardiovascular disease, multiple meta-analyses have debated whether functional improvement is significant or not. The cardiac differentiation from MSC is achievable using cardiogenic factors, however, the high...
Autores principales: | Cho, Dong Im, Kang, Wan Seok, Hong, Moon Hwa, Kang, Hye Jin, Kim, Mi Ra, Kim, Min Chul, Kim, Yong Sook, Ahn, Youngkeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546480/ https://www.ncbi.nlm.nih.gov/pubmed/28498815 http://dx.doi.org/10.18632/oncotarget.17471 |
Ejemplares similares
-
Intramyocardial Injection of Stem Cells in Pig Myocardial Infarction Model: The First Trial in Korea
por: Kim, Min Chul, et al.
Publicado: (2017) -
Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin
por: Kim, Yong Sook, et al.
Publicado: (2013) -
Protective role of 5-azacytidine on myocardial infarction is associated with modulation of macrophage phenotype and inhibition of fibrosis
por: Kim, Yong Sook, et al.
Publicado: (2014) -
Natural product derivative BIO promotes recovery after myocardial infarction via unique modulation of the cardiac microenvironment
por: Kim, Yong Sook, et al.
Publicado: (2016) -
Adjuvant role of macrophages in stem cell-induced cardiac repair in rats
por: Lim, Soo yeon, et al.
Publicado: (2018)